Purchase Order FA864921P0660

The Defense Health Agency has awarded a $249,969 Small Business Innovation Research (SBIR) Phase I contract to Emergingdx Inc., a Lowell, Massachusetts-based diagnostic technology company, for the development of an integrated multiplexed low-cost diagnostic platform for rapid microbial identification. This total small business set-aside contract, designated as a purchase order with firm fixed price terms, represents the initial phase of research and development aimed at advancing medical...

This federal contract award to Prenosis, Inc., a self-certified small disadvantaged business based in Chicago, Illinois, is for research and development services to develop a predictive analytics point-of-care system to predict disease severity due to infection. The $4,308,629.81 cost-plus-fixed-fee contract was awarded on September 20, 2021 by the Defense Threat Reduction Agency (DTRA), a defense agency, with a period of performance through March 30, 2026. The contract is not set-aside....

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a Small Business Innovation Research (SBIR) contract to Sky Park Labs LLC, a small business based in Concord, Massachusetts. The $298,496.00 fixed-price contract is for the development of artificial intelligence (AI) technology to improve clinical microscopy for the diagnosis of infectious diseases. This contract is not set aside for small business participation. Sky Park Labs specializes in applying AI and machine...

The Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded a definitive cost-plus-fixed-fee contract to 4J Therapeutics Inc. for development of an antiviral medical countermeasure on September 30, 2024, with a ceiling value of $330.1 million and ultimate completion date of March 31, 2032. The contract funds assembly of the preclinical package for LNA14, performance of a Phase 1A study in healthy adult human subjects, and demonstration of the awardee's programmable...

The Office of the Assistant Secretary for Preparedness and Response awarded a $20 million definitive contract to Prenosis, Inc. on September 30, 2025, for host-based diagnostics and expansion of the Immunix platform for precision medicine in severe acute respiratory infections and ARDS. Place of performance is Chicago, IL. The contract runs through August 1, 2029, under firm fixed-price terms with no set-aside applied. Prenosis, Inc. is a small disadvantaged business that develops AI-enabled...

The Office of the Assistant Secretary for Preparedness and Response awarded a $135.2 million definitive contract to Gigagen Inc. for next-generation recombinant polyclonal antibody discovery platform development for medical countermeasures on September 25, 2024, under a cost-plus-fixed-fee pricing structure with no set-aside. Place of performance is San Carlos, California. The originating BARDA solicitation, posted September 26, 2023, seeks advanced research and development of medical...

The Defense Threat Reduction Agency has awarded a $167.5K Small Business Innovation Research Phase I contract to Inferlink Corp, a Los Angeles-area artificial intelligence and data analysis firm, to develop generative large language model capabilities for extracting biological and chemical pathways from scientific literature. The contract, awarded October 24, 2024, is designated as a Total Small Business set-aside and carries a completion deadline of May 23, 2025. Inferlink Corp will perform the...

The Office of the Assistant Secretary for Preparedness and Response awarded a $267.6 million definitive contract to Basilea Pharmaceutica International Ltd for the development of antimicrobials to treat resistant fungal and bacterial infections on September 30, 2024, under a cost-sharing pricing model with no set-aside. Place of performance is Switzerland. The contract executes CLIN 0003 under an OTA solicitation and extends through December 31, 2035. The originating BAA, posted in October 2017,...

The Defense Threat Reduction Agency (DTRA) awarded a $167,498 Small Business Innovation Research (SBIR) Phase I contract to Novateur Research Solutions LLC on September 23, 2024, for the project titled "Deep Learning and Extraction of Chemical Synthesis or Biosynthetic Pathways from Scientific Literature (SOTERIA)." This total small business set-aside contract, structured as a firm fixed-price purchase order, is set to conclude on April 22, 2025, and will be performed in Ashburn,...

The National Institute of Allergy and Infectious Diseases awarded a definitive contract to GE Medical Systems Information Technologies, Inc. for development of in vitro diagnostics for biodefense, antimicrobial resistant infections (AMR), and emerging infectious diseases on September 18, 2024, with a ceiling value of $9,673,642 under cost-no-fee pricing. The contract originated from BAA2023-1 Research Area 004, posted January 11, 2023 with a due date of April 11, 2023, and carries no set-aside...